O USO DA TOXINA BOTULÍNICA COMO TERAPIA ADJUVANTE AO TRATAMENTO DA CEFALEIA TENSIONAL EM PACIENTE PORTADORA DE SÍNDROME FIBROMIÁLGICA – RELATO DE CASO.

Abstract

The Botulinum Toxin Type A (BTX-A) can be used as an adjuvant therapy for tensiontype headache in patients with Fibromyalgia Syndrome (FMS). The investigative problem lies in the complexity of managing FMS and its manifestations, and the coexistence with tension-type headache, for which therapeutic Options are limited. This study aims to report a clinical case involving the application of BTX-A in a patient with FMS, in addition to assess the effectiveness and safety of this approach, considering its impact on the quality of life. The study adopts a clinical case approach with qualitative analysis of the results. The theoretical and methodological references encompass concepts related to FMS, the effects of BTX-A on reducing muscle contraction, and the relationship between fibromyalgia and tension-type headache. Partial results demonstrate a significant reduction in the intensity and frequency of tension-type headache, as well as in muscle contraction, after treatment with BTX-A. The study contributes to the understanding of these complex conditions, and suggests BTX-A as a promising therapeutic option. However, more comprehensive research is needed to validate these results and expand therapeutic options available for FMS patients.